CONSORT MEDICAL ACQUIRES AESICA PHARMACEUTICALS.

The Board of Consort Medical plc, has agreed to the terms to acquire the entire issued and to be issued share capital of Aesica Pharmaceuticals Limited for [pounds sterling]230 million. The closing of the transaction, which is expected to occur in November, is conditional on the approval of Consort Medical's shareholders and clearance by the German competition authorities.

Consort Medical plc is a UK company listed on the London Stock Exchange focused on developing and manufacturing disposable medical devices for drug delivery including inhaled, nasal and injectables products through its core operating division Bespak.

Aesica is a European pharmaceutical CDMOs, providing contract development and manufacturing services for Finished Dose and Active Pharmaceutical Ingredients (API) to the global pharmaceutical industry. Since the Aesica business was established in 2004, it has grown both organically and through acquisitions and has established key strategic relationships with major global blue-chip pharmaceutical companies.

About Aesica

Aesica supplies contract development and contract manufacturing services for Finished Dose and Active Pharmaceutical Ingredients to a host of pharmaceutical companies and emerging biotechnology organizations. Silverfleet Capital invested in Aesica in 2011 and over the last three years has worked with the management team to establish the company as one of the top ten CDMOs in the world. The company employs approximately 1,300 people.

About Consort Medical

Consort Medical is an international healthcare company, focused primarily on developing and manufacturing disposable medical devices for drug delivery. The Group has more than 50 years' experience providing services to the pharmaceutical industry. The principal business of Consort Medcial is the management of its core operating division, Bespak, a developer and manufacturer of drug delivery devices for pharmaceutical partner companies, including inhaled, nasal, and injectables products. Consort Medical works with more than 50 pharmaceutical companies (excluding its Bespak medical device customer base for medical check valves). With its headquarters in Hemel Hempstead, Consort Medical employs approximately 830 people across its manufacturing and R&D facilities in King's Lynn, Cambridge, Milton Keynes and Nelson in the UK.

For more information, visit aesica-pharma.co.uk.